583 related articles for article (PubMed ID: 18250251)
41. Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study.
DeSantis SM; Bandyopadhyay D; Baker NL; Randall PK; Anton RF; Prisciandaro JJ
Drug Alcohol Depend; 2013 Sep; 132(1-2):244-50. PubMed ID: 23566774
[TBL] [Abstract][Full Text] [Related]
42. Medication-enhanced behavior therapy for alcohol use disorder: Naltrexone, Alcoholics Anonymous Facilitation, and OPRM1 genetic variation.
Stewart SH; Walitzer KS; Blanco J; Swiatek D; Paine Hughes L; Quiñones-Lombraña A; Shyhalla K
J Subst Abuse Treat; 2019 Sep; 104():7-14. PubMed ID: 31370987
[TBL] [Abstract][Full Text] [Related]
43. Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial.
Ray LA; Green R; Roche DJO; Bujarski S; Hartwell EE; Lim AC; Rohrbaugh T; Ghahremani D; Hutchison K; Miotto K
Alcohol Clin Exp Res; 2018 Mar; 42(3):613-623. PubMed ID: 29265379
[TBL] [Abstract][Full Text] [Related]
44. Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach.
Sluiter RL; Kievit W; van der Wilt GJ; Schene AH; Teichert M; Coenen MJH; Schellekens A
Eur Addict Res; 2018; 24(5):245-254. PubMed ID: 30384381
[TBL] [Abstract][Full Text] [Related]
45. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
46. Population-specific effects of the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1) on HPA-axis activation.
Hernandez-Avila CA; Covault J; Wand G; Zhang H; Gelernter J; Kranzler HR
Pharmacogenet Genomics; 2007 Dec; 17(12):1031-8. PubMed ID: 18004207
[TBL] [Abstract][Full Text] [Related]
47. Association of functional opioid receptor genotypes with alcohol dependence in Koreans.
Kim SG; Kim CM; Kang DH; Kim YJ; Byun WT; Kim SY; Park JM; Kim MJ; Oslin DW
Alcohol Clin Exp Res; 2004 Jul; 28(7):986-90. PubMed ID: 15252283
[TBL] [Abstract][Full Text] [Related]
48. The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers.
Mitchell JM; Fields HL; White RL; Meadoff TM; Joslyn G; Rowbotham MC
J Clin Psychopharmacol; 2007 Feb; 27(1):112-5. PubMed ID: 17224736
[No Abstract] [Full Text] [Related]
49. Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response.
Gueorguieva R; Wu R; Krystal JH; Donovan D; O'Malley SS
Addict Behav; 2013 May; 38(5):2119-27. PubMed ID: 23435273
[TBL] [Abstract][Full Text] [Related]
50. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial.
Lerman C; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Restine S; Shields PG; Kaufmann V; Redden D; Benowitz N; Berrettini WH
Pharmacogenomics J; 2004; 4(3):184-92. PubMed ID: 15007373
[TBL] [Abstract][Full Text] [Related]
51. Pharmacogenetics of alcoholism: a clinical neuroscience perspective.
Ray LA; Courtney KE; Bujarski S; Squeglia LM
Pharmacogenomics; 2012 Jan; 13(2):129-32. PubMed ID: 22256863
[No Abstract] [Full Text] [Related]
52. Human mu-opioid receptor variation and alcohol dependence.
Sander T; Gscheidel N; Wendel B; Samochowiec J; Smolka M; Rommelspacher H; Schmidt LG; Hoehe MR
Alcohol Clin Exp Res; 1998 Dec; 22(9):2108-10. PubMed ID: 9884158
[TBL] [Abstract][Full Text] [Related]
53. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.
COMBINE Study Research Group
Alcohol Clin Exp Res; 2003 Jul; 27(7):1123-31. PubMed ID: 12878918
[TBL] [Abstract][Full Text] [Related]
54. Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial.
Garbutt JC; Kampov-Polevoy AB; Kalka-Juhl LS; Gallop RJ
JAMA Psychiatry; 2016 Oct; 73(10):1056-1063. PubMed ID: 27627782
[TBL] [Abstract][Full Text] [Related]
55. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
[TBL] [Abstract][Full Text] [Related]
56. Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.
Ray LA; Oslin DW
Drug Alcohol Depend; 2009 Dec; 105(3):256-8. PubMed ID: 19717248
[TBL] [Abstract][Full Text] [Related]
57. Gender differences in the genetic risk for alcohol dependence--the results of a pharmacogenetic study in Korean alcoholics.
Kim SG
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Dec; 44(6):680-5. PubMed ID: 20077761
[TBL] [Abstract][Full Text] [Related]
58. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
Farren CK; Scimeca M; Wu R; Malley SO
Drug Alcohol Depend; 2009 Jan; 99(1-3):317-21. PubMed ID: 18644685
[TBL] [Abstract][Full Text] [Related]
59. Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.
Fucito LM; Park A; Gulliver SB; Mattson ME; Gueorguieva RV; O'Malley SS
Biol Psychiatry; 2012 Nov; 72(10):832-8. PubMed ID: 22541040
[TBL] [Abstract][Full Text] [Related]
60. Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus.
Barr CS; Chen SA; Schwandt ML; Lindell SG; Sun H; Suomi SJ; Heilig M
Biol Psychiatry; 2010 Jan; 67(1):78-80. PubMed ID: 19748082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
